Upregulation of the ligand results from stimulation by proinflammatory cytokines including IFN-γ which is produced by lymphocytes already existing in the tumor microenvironment [19] providing another association between PD-1/PD-L1 immune checkpoint pathway activation and cancer. The gene discussed is PDCD1; the disease is neoplasm.